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Abstract
Purpose—To study the effects of noninvasive transcranial focal electrical stimulation (TFS) via
tripolar concentric ring electrodes (TCRE) on the electrographic and behavioral activity from
pentylenetetrazole (PTZ)-induced seizures in rats.
Methods—The TCREs were attached to the rat scalp. PTZ was administered and, after the first
myoclonic jerk was observed, TFS was applied to the TFS treated group. The
electroencephalogram (EEG) and behavioral activity were recorded and studied.
Results—In the case of the TFS treated group, after TFS, there was a significant (p = 0.001)
decrease in power compared to the control group in delta, theta, and alpha frequency bands. The
number of myoclonic jerks was significantly different (p = 0.002) with median of 22 and 4.5 for
the control group and the TFS treated groups, respectively. The duration of myoclonic activity was
also significantly different (p= 0.031) with median of 17.56 min for the control group versus 8.63
min for the TFS treated group. At the same time there was no significant difference in seizure
onset latency and maximal behavioral seizure activity score between control and TFS treated
groups.
Conclusions—TFS via TCREs interrupted PTZ-induced seizures and electrographic activity
was reduced towards the “baseline.” The significantly reduced electrographic power, number of
myoclonic jerks, and duration of myoclonic activity of PTZ-induced seizures suggests that TFS
may have an anticonvulsant effect.
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INTRODUCTION
During recent years, electrical stimulation of the brain has shown promise in reducing
seizure frequency. Implantable techniques such as the deep brain stimulation (DBS)
(Chabardes et al. 2002, Vonck et al. 2002, Kerrigan et al. 2004, Usui et al. 2005, Velasco et
al. 2005), the responsive neurostimulator (RNS) (Kossoff et al. 2004, Goodman et al. 2005),
and the vagus nerve stimulation (VNS) (Ben-Menachem et al. 1994, The VNS Study Group
1995, Handforth et al. 1998, George et al. 2000, Patwardhan et al. 2000), trigeminal nerve
stimulation (Fanselow et al. 2000, DeGiorgio et al. 2003) have been widely studied.
Noninvasive forms of brain stimulation for epilepsy are also receiving increasing attention.
There is a growing body of research on different forms of noninvasive electrical stimulation
including transcranial magnetic stimulation (TMS) (Wassermann 1998, Hallett 2002,
Theodore et al. 2002, Tassinari et al. 2003) and transcranial direct current stimulation
(tDCS) (Fregni et al. 2006). Yet, as previously concluded by Theodore and Fisher (2004) in
a review of various brain stimulation techniques, the best structures to stimulate and the
most effective stimuli to use are still unknown.
Concentric ring electrodes have unique capabilities. They perform the second spatial
derivative, i.e. the Laplacian, on the surface potentials. Previously we have shown that
Laplacian electroencephalography (EEG) with the tripolar concentric ring electrode (TCRE)
configuration (Fig. 1, panel A) has significantly better spatial selectivity, signal-to-noise
ratio, localization, approximation of the analytical Laplacian, and mutual information than
conventional EEG with disc electrodes (Besio et al. 2004a, Besio et al. 2006a, Besio et al.
2006b, Koka & Besio 2007). These findings suggest that EEG with TCREs (tEEG) may be
superior at detecting seizures or other neurological disorders than conventional EEG with
disc electrodes.
Unlike electrical stimulation between two conventional disc electrodes applied across the
head, electrical stimulation via concentric ring electrodes has a much more uniform current
density (Wiley and Webster, 1982) and focuses the stimulation directly below the
electrodes. Therefore, we call this form of stimulation transcranial focal electrical
stimulation (TFS).
An important advantage of TFS is that it does not cause motor contractions as is common
with electroconvulsive therapy, another form of transcranial electrical stimulation. The rats
do not show signs of pain or aversion when TFS is applied via TCRE and continue to roam
freely. The effects of TFS via concentric ring electrodes (CREs) on rat skin were
quantitatively analyzed in (Besio et al. 2010) through calculation of the temperature profile
under the CRE and the corresponding energy density with electrical-thermal coupled field
analysis using a three-dimensional multi-layer model. Infrared thermography was also used
to measure skin temperature during electrical stimulation to verify the computer simulations.
Histological analysis was performed to study cell morphology and characterize any resulting
tissue damage. It was concluded that as long as the specified energy density applied through
the CRE was kept below 0.92 (A2/cm4s−1), the maximum temperature will remain within
the safe limits and also within the limits of the melting point of conductive paste and provide
a safe current density distribution. Effects of TFS via TCRE on rat cortical integrity were
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studied in (Mucio-Ramirez et al. 2011). Histomorphological analysis was used to assess
cortical areas below the TFS site for neuronal damage. Control and TFS treated animals
were anaesthetized and transcardially perfused. The brains were removed, post-fixed, and
cut into coronal sections. Slices were mounted on gelatinized slides, Nissl stained for
brightfield analysis, and photographed with a microscope equipped with a digital camera.
Images where digitized to grayscale and the integrated optical density was measured with
densitometry software. No significant difference in integrated optical density values was
found for control and TFS-treated rat brains and morphological analysis did not show any
pyknotic neurons, cell loss or gliosis that might confirm any neuronal damage.
Previously Besio et al. achieved promising results using TFS to attenuate acute seizures in a
pilocarpine-induced status epilepticus (SE) model (Besio et al. 2007). Pilocarpine is a
cholinergic muscarinic agonist. After the application of TFS via concentric ring electrodes,
the electrographic activity visually resembled the “baseline” activity and the behavioral
seizure activity was reduced (Besio et al. 2007). The seizure activity still had not returned
for two or more hours after the stimulation (Besio et al. 2007).
To further validate TFS Besio et al. extended the prior work by testing the effect of TFS via
concentric ring electrodes in a second animal model - a pentylenetetrazole (PTZ) induced rat
seizure model, which is one of the most commonly used models for testing anticonvulsant
effects. PTZ is a GABAA receptor antagonist allowing us to evaluate TFS on another
mechanism of seizure induction. As a first step, TFS was shown to reduce pathological
synchronization of PTZ-induced electrographic activity within the beta-gamma frequency
bands (Besio et al. 2011). In this study we expand our analysis of the effect of TFS on both
electrographic and behavioral activity and summarize our findings.
METHODS
We now report on the use of longer electrographic activity time windows (15 minutes long)
analyzed to confirm if TFS has long-lasting effects. For behavioral activity, four different
metrics were used including the latency of the seizure onset, the number of myoclonic jerks
(MJs), duration of myoclonic activity and the maximal behavioral seizure activity score to
better assess the effect(s) of TFS.
Data collection
Data collection for this study was performed separately for two parts of the study
corresponding to assessment of the effect of TFS on (1) electrographic activity (EA) and (2)
behavioral activity (BA) respectively. The two parts of the study were conducted in two
different laboratories and data collection protocols have differed slightly in such aspects as
type and amount of anesthesia given and amount of PTZ given. These differences are
specified in the corresponding sections of the manuscript. Because of this inconsistency in
the data collection process the corresponding data were processed separately for the EA and
BA parts of this study to avoid the possibility of inconsistency influencing the obtained
results.
Animal preparation
Our animal protocol was approved by the University of Rhode Island IACUC.
Approximately 24 h before the induction of seizures, an adult male 220~320g Sprague-
Dawley rat was given either 80 mg/kg of ketamine and 12 mg/kg xylazine i.p. (EA) or 120
mg/kg of ketamine i.p. (BA) for brief anesthesia. The rat scalp was shaved and prepared
with NuPrep abrasive gel (D. O. Weaver & Co., Aurora, CO, USA). Three custom-designed
TCREs (Besio et al., 2006a) were applied to the rat scalp using conductive paste (0.5 mm
Besio et al. Page 3
Epilepsy Res. Author manuscript; available in PMC 2014 July 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Ten20, Grass Technologies, RI, USA) and adhered with Teets dental acrylic (Pearson Lab
Supply, Sylmar, CA, USA).
As shown in Fig. 1 panel A one TCRE (diameter = 1.0 cm), was centered on the top of the
head (1). The front edge of the electrode was placed near the site that should be the bregma
since we were not able to see it. The TFS (300 Hz, 50 mA, 200 μs, biphasic square pulses
for 2 minutes) was administered once between the outer ring and the central disc of
electrode (1). Two other TCRE recording electrodes (diameter = 0.6 cm) were placed
bilaterally behind the eyes, but in front of the ears (A 2.0 mm, L 9.0 mm relative to the
central electrode) on both sides of the head (2,3). An isolated ground electrode was attached
on the top of the neck behind the ears (g). These particular electrode locations were chosen
due to size constraints and brain anatomy of adult rats. The electrodes were made of gold-
plated copper. The rat was returned to its cage and allowed food and water ad libitum for
approximately 24 h until the experimental procedure began. All experiments were
performed in the afternoon. Flow charts of the experimental procedures for the EA and BA
parts of this study are presented in panels A and B of Fig. 2 respectively.
Electrographic activity
Recording system—The Laplacian EEG signals were preamplified (gain 100 and 0.3 Hz
high pass filter) with a custom built preamplifier and then amplified using a Grass Model
NRS2 Neurological Research System with Model 15A54 AC amplifiers (Grass
Technologies, West Warwick, RI, USA) with a gain of 1000 and band pass of 1.0–100 Hz
with the 60 Hz notch filter active, and digitized (16 bits, 256 S/s).
tEEG—Two differential signals from each electrode (Fig. 1, panel B) were combined
algorithmically for a tEEG derivation (Fig. 1, panel C) of the signal as reported previously in
(Besio et al., 2006a). Briefly, the algorithm is two-dimensional and weights the middle ring
and central disc difference sixteen times greater than the outer ring and central disc
difference. For each rat the data recorded from one electrode was selected for further
analysis based on the signal-to-noise ratio, skin-to-electrode impedance, and visual
inspection for presence of artifacts. All the signal processing was performed using Matlab
(Mathworks, Natick, MA, USA).
Power spectral density analysis—Grand average power spectral density (PSD)
estimates were calculated to compare different stages of seizure development. Three thirty-
second long segments were processed for each rat. These segments were selected in the
same way for control and TFS treated groups. In both groups the “baseline” segment was
selected during the time period when the rats were relatively still for at least 30 seconds
resulting in artifact free baseline tEEG. The “pre-TFS” and “post-TFS” segments were
selected starting 30 s before and 2.5 min after the first R = 3 MJ, respectively. For the
control group the “post-TFS” segment was emulating the time after the application of TFS
would have been stopped for a TFS treated rat. Shifts of up to 10 s were allowed to obtain
the most artifact-free segments possible. For the TFS treated group, Pre-TFS segments were
selected in such a way to contain the electrographic activity that preceded the first R = 3 MJ
that was detected as the cue to turn the TFS on. Post-TFS segments were selected to account
for a small delay due to manually changing the electrode from recording to stimulation and
back, to let the amplifiers recover from the application of 2 min long TFS, and to start as
soon after the amplifiers recover as possible before the rats started roaming and eating
causing movement artifacts.
First, for each rat the tEEG segments were demeaned and filtered 1.0–30 Hz. Next, Welch’s
method (Barbé et al. 2010) was used to calculate the PSD estimates for each segment
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(window size and the number of points for Fast Fourier Transform equal to 256, 50%
window overlap, Hamming window). Finally, PSD estimates were averaged to produce
grand average estimates for all control and all TFS treated rats respectively.
Statistical analysis—The generalized likelihood ratio test (GLRT, Kay 1998) was used
to compare the average power of electrographic seizure activity between the TFS treated and
control groups. Since the exact values of power to be compared are generally unknown a
composite hypothesis test is needed to accommodate unknown parameters. Although there is
no optimality associated with the GLRT it is widely used in practice due to its ease of
implementation and less restrictive assumptions (Kay 1998).
For each rat 900 s (15 min) long segments of data were processed. The segments for both
control and TFS treated groups began 3 minutes after the first R = 3 MJ to account for the
duration of TFS and recovery of the amplifiers (TFS treated group). Since the segments
compared must be equal length for GLRT, the length of all segments was set equal to the
minimal length of the recording for all the rats. Each extracted segment was de-meaned. By
de-meaning the power of the segments was equal to their sample variance (Shiavi 2007).
Assuming the segments were white Gaussian noise with unknown variance the test
hypotheses were defined in the following way: under the null hypothesis variances of two
segments corresponding to control and TFS treated rats respectively were equal meaning
that TFS was not effective. The alternative being the variance for the segment corresponding
to the TFS treated rat is less than the variance for the control rat. The GLRT was applied to
segment pairs of control and TFS treated groups verifying the difference in variance and the
results were then averaged for all the pairs.
Behavioral activity
Behavioral activity metrics—After the administration of PTZ the following stages were
used to score seizure-related behavioral activity (Mirski et al. 1997): R = 0, no seizure
activity; R = 1, oral-facial movements only; R = 2, head nodding; R = 3, MJ; R = 4, forelimb
clonus; R = 5, rearing; R = 6, severe clonic activity with rearing and falling. The latency for
behavioral seizure activity was defined as the time to the first MJ, R = 3. The maximal R
value and the total number of MJs were counted (first to last) for each animal as well as the
duration of myoclonic activity (the duration was the time elapsed between the first and the
last MJs). Statistical analysis: Given the non-normality of distribution (Ryan-Joiner test) of
at least one of the two samples for all four behavioral seizure activity metrics the non-
parametric unpaired Mann–Whitney U test was used to compare the results obtained for TFS
and control groups.
RESULTS
Electrographic activity
A total of 10 TFS treated rats and 10 controls were used to assess the effect of TFS on
electrographic seizure activity. Electrographic seizure activity preceded behavioral activity
and appeared as clear short high-frequency bursts and sometimes continued after the
behavioral activity had ceased. Figure 3 panel A shows 30 s segments of tEEG for a typical
control rat. The top (blue) trace shows the “baseline” tEEG prior to the administration of
PTZ, the middle (red) trace shows the PTZ-induced seizure activity just before the first R =
3 MJ and prior to the application of TFS, and the bottom (green) trace showing the tEEG 2.5
minutes after the first MJ emulating the segment just after the application of TFS would
have been stopped for a TFS treated rat. Figure 3 panel B shows similar segments for a
typical TFS treated rat. For the TFS treated rat, the bottom (green) trace is from 2.5 min
after the first MJ immediately after the application of TFS.
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As illustrated in panels A and B, the “baseline” (blue) traces are quiet while the
administration of PTZ caused an increase in seizure activity in the tEEG of both rats
(middle, red, traces). After the application of TFS, the seizure activity of the TFS treated rat
diminished (bottom, green, trace in panel B). In contrast, the seizure activity of the control
rat continued to persist (bottom, green, trace in panel A).
The corresponding PSD estimates for the traces shown in panels A and B are shown in
panels C and D, respectively. The “baseline” (blue traces in both panels C and D) has the
least power across the spectrum. After the administration of PTZ, the tEEG power of both
rats increased (red traces in panels C and D). After the application of TFS, the power for the
TFS treated rat is reduced toward the baseline (green trace in panel D). In contrast, the
power of the tEEG higher frequencies for the control rat continued to increase (green trace
in panel C).
Grand average PSD estimates for control and TFS treated groups are presented in Fig. 4. As
in the case of individual rats, it can be seen from the figures that while administration of
PTZ caused increases in power of the tEEG for both groups which is expected since PTZ
induces high-frequency electrographic spiking activity, there is a difference between the
TFS treated group and the control group. For the TFS treated group (Fig. 4, panel B), after
TFS, the PSD was reduced further towards a pre-seizure “baseline” than it was for the
control group (Fig. 4, panel A) in delta (1 - 4.5 Hz), theta (5 – 8.5 Hz), and alpha (9 – 13.5
Hz) frequency bands (comparison of red and green traces).
The signal power calculated on per second basis for segments corresponding to control and
TFS treated groups are presented in panels A and B of Fig. 5 respectively. The GLRT results
show that TFS significantly (p = 0.001) reduced the power of electrographic seizure activity
in the TFS treated group compared to controls in 87% of the segment pairs.
Figure 6 provides an example of superimposition of the electrographic and the behavioral
activities for two representative animals: one TFS-treated (panels A-B) and one control
(panels C-E). Panels A and C are spectrograms of the tEEG signals with panel A
representing signals from a rat who received TFS at the onset of PTZ-induced seizure (black
block shows when the TFS was on). Panels B and D show the tEEG waveforms
corresponding to the spectrograms in panels A and C respectively. The top row of panels A
and C (turquoise background) shows when the PTZ was given (dark blue mark) as well as
any behavioral seizure activity corresponding to stages R ≥ 3 (red marks). It should be noted
that the animals presented in Fig. 6 were originally used for the EA part of this study. As
such they received a higher dose of PTZ than the rats from the BA part of the study (55 vs.
45 mg/kg respectively). Because of this, the animals for Fig. 6 experienced stronger seizures
with faster progression from MJs to higher R stages like tonic-clonic seizures and, therefore,
smaller numbers of MJs compared to results obtained in the BA study. For an accurate
representation of behavioral activity in Fig. 6 all seizure activity corresponding to stages
equal or higher than MJ (R = 3) was selected for inclusion in the figure.
As can be seen from Fig. 6 the TFS-treated rat had significantly shorter electrographic and
behavioral seizure activities unlike the control rat who was having a tonic-clonic seizure for
almost 800 seconds. The spectrogram for the control rat (panel C) shows that there was
more power in the higher frequencies during tonic-clonic seizure than there was during the
baseline or after the seizure stopped while the rat was roaming, chewing, and grooming.
This is a clear sign that tEEG greatly attenuates severe movement/muscle artifacts. Panel E
is an expanded portion of the tEEG in panel D during the tonic-clonic stage showing clear
seizure activity and the lack of muscular and movement artifacts.
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Behavioral activity
A total of 18 TFS treated and 20 control rats were used to assess the effect of TFS on
behavioral seizure activity. Out of 20 controls, 14 rats were used twice, first as part of the
TFS treated group and then as a control 1-2 days after the TFS treatment. This was done to
minimize the effect of variability (resistance to PTZ, etc) among the rats of both groups and
to allow the within-subject comparison.
Number of MJs—Figure 7 shows a comparison of the number of MJs between the control
group (n = 20) and the TFS treated group (n = 18). The number of MJs was measured from
the first MJ until the last. There was a statistically significant difference in the number of
MJs with a median of 22 for the control group and 4.5 for the TFS treated group (p = 0.002).
Duration—Figure 8 shows a comparison of the durations of MJ activity in minutes
between the control group (n = 20) and the TFS treated group (n = 18). The duration of MJs
was time elapsed from the first MJ until the last. There was a statistically significant
difference in duration with a median of 17.56 min for the control group and 8.63 min for the
TFS treated group (p = 0.031).
Seizure onset latency and the maximal behavioral activity score—There was no
statistically significant difference in seizure onset latency with a median of 108.5 s for the
control group and 112 s for the TFS treated group (p = 0.63). Neither was there a statistically
significant difference in the maximal behavioral activity score with a median of R = 5 for
the control group and R = 4.5 for the TFS treated group (p = 0.78)
DISCUSSION
Anticonvulsant effect
Our present results show that TFS significantly reduced PTZ-induced seizures. After the
application of TFS, the electrographic activity of TFS treated rats was reduced towards the
“baseline”, suggesting that TFS may have an anticonvulsant effect. We expected the power
to increase during the PTZ-induced seizures and be greater than the “baseline” activity
because PTZ induces high-frequency electrographic spiking activity. This increased
electrographic activity and the resultant increased power can be observed in both typical rats
(red traces in Fig. 3 panels A/B and C/D, respectively) and group grand averages (red traces
in Fig. 4 panels A/B). After applying TFS, the power of the electrographic activity of the
TFS treated rats was reduced further towards the pre-seizure baseline levels compared to
controls in delta, theta and alpha frequency bands. This reduction is evident in both typical
rats (green traces in Fig. 3 panels A/B and C/D, respectively) and the group grand averages
(green traces in Fig. 4 panels A/B). For the control rats, which were not treated with TFS,
we expect the seizure electrographic activity to continue until PTZ diminishes so that it no
longer interferes with brain activity. Evidence of PTZ-induced seizure activity still
persisting in the control rat can be clearly seen from the green traces in Fig. 3 panels A and
C. Unsurprisingly, the power of the seizure electrographic activity for the control rat (green
trace in Fig. 3 panel C) continued to rise due to the effect of the PTZ still enhancing the
seizure.
TFS also led to a reduction in the number of MJs. This provides further evidence that TFS
has an anticonvulsant effect. Figure 7 shows that the median number of MJs was 22 for the
control group and 4.5 for the TFS treated group. The dramatic reduction in the number of
MJs is not surprising because there was also a significant reduction in the duration of the
myoclonic activity after TFS was applied, as illustrated in Fig. 8. At the same time there was
no significant difference in seizure onset latency and the maximal behavioral activity score
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between control and TFS treated groups. Figure 6 further illustrates the potential of TFS to
reduce both electrographic and behavioral seizure activity showing their superimposition for
typical TFS-treated and control rats.
Model selection
The PTZ seizure model is one of the most commonly used models for testing anticonvulsant
effects (De Sarro 1999, Fisher 1989, Sarkisian 2001). PTZ, a GABAA antagonist, is well
documented for eliciting traits from absence-like seizures to generalized tonic-clonic
seizures (Fisher 1989). Depending upon the dose of PTZ given, it is possible to have any of
several endpoints: arrest and staring, MJs, limbic seizures (facial and forelimb clonus with
rearing), clonic convulsive seizures, and tonic extensor seizures and is used for seizure
susceptibility and screening of new drugs (Sarkisian 2001). Small doses of PTZ given
repeatedly provoke chemical kindling (De Sarro 1999).
Data segment selection
An important advantage of our approach to selection of 30 s segments preceding and
following the application of TFS was consistency for both the control and TFS treated
groups. Time-synchronized data segmentation allowed us to directly compare between
corresponding traces. However, this data segmentation approach has significant
disadvantages. First, starting the segment 2.5 min after the first MJ, in order to minimize
movement artifacts, may not have allowed enough time for the amplifiers in some channels
to recover after the application of TFS for the TFS treated rats causing high frequency noise.
We believe that this noise is attributing to higher power in the beta (14 – 31.5 Hz) frequency
band (green trace in Fig. 4 panel B). Second, as can be seen in Fig. 5 electrographic activity
caused by PTZ-induced seizures is highly variable with periods of intense spiking activity
interchanging with quiet periods with very low activity intensities. Strict guidelines for data
segment selection causes vulnerability to selecting data segments partially or fully during
quiet periods making them less representative of the induced seizure activity. The only way
to reduce the effect of this nuisance factor is to use grand average PSD estimates as was
done in this study. For conclusive proof that TFS significantly reduced the power of
electrographic seizure activity in the TFS treated group compared to controls GLRT was
used on significantly larger (15 min long) segments of data.
Other noninvasive/minimally invasive brain stimulation techniques
The effect of TFS on seizures was first reported by Besio (Besio et al. 2004b). This original
research was conducted with a intracisternal penicillin model in rats. Our current findings
that TFS reduced the electrographic activity, duration, and number of MJs of PTZ-induced
seizures in rats are consistent with the results previously achieved with pilocarpine-induced
SE in rats (Besio et al. 2007).
Patwardhan et al. (2005) found that noninvasive electrical stimulation via ear bars captured
penicillin-induced seizures in rats. Patwardhan et al. generated seizures to control seizures.
The stimulation, via ear bars, also caused strong tonic activity.
Cathodal tDCS, applied on the skull of rats, was found by Liebetanz et al. (2006) to
significantly alter the threshold for localized seizure activity (TLS) induced with a
transcranial cortical ramp-stimulation. They found significant differences in the TLS, due to
30 minutes of tDCS applied on the skull prior to ramp-stimulation that lasted up to 90
minutes after stopping the tDCS. We have not tested TFS on the transcranial cortical ramp-
stimulation model of focal epilepsy however we have found similar long lasting effects on
PTZ-induced seizures. Fig. 8 illustrates how TFS decreased the duration of PTZ-induced
myoclonic seizure activity which on average lasted 18 min in the control group. If TFS had
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no lasting effect the mean duration would be the same for both groups. However, it appears
that the short two-minute TFS lasts at least 18 min, nine times longer than it was applied.
Similar to Liebetanz, Kamida et al. (2011) also used cathodal tDCS applied on the skull.
They applied tDCS after administering pilocarpine-induced status epilepticus (SE) in
immature rats. They found reductions in cell loss, cognitive impairment, and frequency of
convulsions as a result of the stimulation. Kamida et al. applied tDCS for two consecutive
weeks starting two days after the termination of SE. In contrast Besio et al. (2007) applied
TFS for one or two minutes, on the scalp, 5 minutes after the onset of pilocarpine-induced
SE which stopped or reduced electrographic and behavioral activity and was also long
lasting.
Seizure reduction has also been reported using TMS on seizing rats. Akamatsu et al. (2001)
found a significant increase in latency to PTZ-induced myoclonic and tonic-clonic
behavioral activity due to 0.5 Hz repeated TMS (rTMS). Rotenberg et al. (2008) found that
rTMS at frequencies of 0.5 and 0.75 Hz, manually triggered by the onset of EEG seizure
activity, reduced the duration of individual PTZ-induced seizures. In contrast we
administered TFS after the first MJ, when the seizure is quite severe, rather than before
administering PTZ or after the first electrographic signs of seizures and found a significant
reduction in the total duration of behavioral PTZ-induced MJs due to TFS.
Limitations of the methods
For the placement of the stimulation electrode (1) we are certain there are variations in
where the electrodes are placed from rat-to-rat. There is no definite way, noninvasively, to
determine exactly where the electrode is placed relative to brain structures. It is also
unknown whether the TFS anticonvulsant effect is from stimulation of peripheral nerves in
the skin, meninges, brain, or something else. We are not able to implant electrodes into the
brain to conclusively determine when the electrographic seizure activity has ceased since
that would compromise the scalp where the TCREs are attached and skull altering TFS
pathways. Therefore, we use the end of MJ activity as endpoint for seizure duration.
Our findings suggest that TFS may have an anticonvulsant effect. In the present study TFS
was administered after the first MJ was observed. In the future, it would also be of interest to
analyze whether applying TFS before administering PTZ or at the first onset of PTZ-induced
electrographic activity blocks the behavioral seizure activity and/or alters the progression of
the electrographic activity.
Finally, we intended this paper to report the results on electrographic and behavioral aspects
independently rather than to integrate and compare them as the direct comparison is not
feasible in this case due to the use of two different groups of animals with different data
collection protocols for two objectives of this study.
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Figure 1.
Schematic representation of the electrode placement and Laplacian derivation of the
acquired signal. The Laplacian algorithm is two-dimensional and weights the middle ring
and central disc signal difference sixteen times greater than the outer ring and central disc
signal difference. Panel A – TFS was applied between the outer ring and the central disc of
electrode (1). Electrodes (1), (2), and (3) were used for recording. Electrode (g) was the
isolated ground electrode. Panel B – two signal differences from each electrode: top (blue)
outer ring and central disc signal difference and bottom (green) middle ring and central disc
signal difference. Panel C – the resulting Lapacian tEEG outputs after combining the signals
of panel B with the Laplacian algorithm (Besio et al. 2006a).
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Figure 2.
Flow charts of the experimental procedures for the electrographic (A) and behavioral (B)
activity parts of this study.
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Figure 3.
Panel A – Control rat. Top (blue) trace: “baseline” tEEG prior to the administration of PTZ.
Middle (red) trace: PTZ-induced seizure activity recorded 30 s before the first MJ and
immediately prior to the application of TFS. Bottom (green) trace: tEEG recorded 2.5 min
after the first MJ emulating the segment just after the application of TFS would have been
stopped for a TFS treated rat. Panel B – TFS treated rat. Top (blue) trace: “baseline” tEEG
prior to the administration of PTZ. Middle (red) trace: PTZ-induced seizure activity 30 s
before the first MJ. Bottom (green) trace: tEEG recorded 2.5 min after the first MJ
immediately after the application of TFS.
Panels C and D show PSD estimates for tEEG segments from panels A and D, respectively.
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Figure 4.
Grand average PSD estimates for the control (A) and TFS treated (B) groups (n = 10 for
each group).
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Figure 5.
Signal power calculated on per second basis for data segments corresponding to control (A)
and TFS treated (B) groups (n = 10 for each group; traces correspond to individual rats).
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Figure 6.
Example of superimposition of the electrographic and the behavioral activities for two
representative animals: one TFS-treated (panels A-B) and one control (panels C-E). Panels
A and C – spectrograms of the tEEG signals with panel A representing signals from a rat
who received TFS at the onset of PTZ-induced seizure (black block shows when the TFS
was on). The top row of panels A and C (turquoise background) shows when the PTZ was
given (dark blue mark and an arrow) as well as any behavioral seizure activity
corresponding to stages R ≥ 3 (red marks and an arrow). Panels B and D – tEEG wavefroms
corresponding to the spectrograms in panels A and C respectively. Panel E – an expanded
portion of the tEEG in panel D during the tonic-clonic stage showing clear seizure activity
and the lack of muscular and movement artifacts.
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Figure 7.
After the application of TFS, the number of MJs in the TFS treated group (n = 18; sample
minimum: 0, maximum: 65, mean: 12.28, first quartile: 1.25, third quartile: 10.75) reduced
to a median of 4.5. This is significantly less (p = 0.002, Mann–Whitney U test) than the
median of 22 for the control group (n = 20; sample minimum: 2, maximum: 374, mean:
53.95, first quartile: 9.75, third quartile: 69.75). Outliers, defined by Minitab, (version 16)
are marked with open circles.
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Figure 8.
After the application of TFS, the duration of myoclonic activity of PTZ-induced seizures in
the TFS treated group (n = 18; sample minimum: 0, maximum: 38, mean: 10.95, first
quartile: 3.08, third quartile: 17.67) reduced to a median of 8.63 min. This is significantly
less (p = 0.031, Mann–Whitney U test) than the median of 17.56 min for the control group
(n = 20; sample minimum: 2.17, maximum: 56.83, mean: 20.28, first quartile: 10.56, third
quartile: 23.56). Outliers, defined by Minitab, (version 16) are marked with open circles.
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